{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:10:10Z","timestamp":1792444210298,"version":"4.5.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007509","name":"Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007509","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020231","name":"Fundacio Catalana de Pneumologia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/00897"],"award-info":[{"award-number":["PI24\/00897"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CD23\/00093"],"award-info":[{"award-number":["CD23\/00093"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.rmed.2025.108593","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:16:06Z","timestamp":1766074566000},"page":"108593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Bronchiectasis and treatable traits: the journey from concept to clinical practice"],"prefix":"10.1016","volume":"251","author":[{"given":"Pau","family":"Marrades","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Iorfida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Perea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Voza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4833-6713","authenticated-orcid":false,"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"174","key":"10.1016\/j.rmed.2025.108593_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0091-2024","article-title":"Epidemiology of bronchiectasis","volume":"33","author":"Nigro","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib4","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1183\/13993003.00499-2019","article-title":"Increasing bronchiectasis prevalence in Germany, 2009-2017: a population-based cohort study","volume":"54","author":"Ringshausen","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"173","key":"10.1016\/j.rmed.2025.108593_bib5","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0055-2024","article-title":"Pathophysiology and genomics of bronchiectasis","volume":"33","author":"Perea","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib6","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1183\/13993003.01899-2015","article-title":"Clinical phenotypes in adult patients with bronchiectasis","volume":"47","author":"Aliberti","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.rmed.2025.108593_bib7","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1513\/AnnalsATS.201507-472OC","article-title":"Etiology of non\u2013cystic fibrosis bronchiectasis in adults and its correlation to disease severity","volume":"12","author":"Lonni","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib8","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1055\/s-0041-1730892","article-title":"Diagnosis and initial investigation of bronchiectasis","volume":"42","author":"Amati","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00777-2021","article-title":"Heterogeneity of treatment response in bronchiectasis clinical trials","volume":"59","author":"Sibila","year":"2022","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108593_bib10","first-page":"6","article-title":"Inflammation: a two-edged sword--the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur. J. Respir. Dis. Suppl."},{"issue":"10150","key":"10.1016\/j.rmed.2025.108593_bib11","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet [Internet]"},{"issue":"12","key":"10.1016\/j.rmed.2025.108593_bib12","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-2600(16)30320-4","article-title":"Comorbidities and the risk of mortality in patients with bronchiectasis: an international multicentre cohort study","volume":"4","author":"McDonnell","year":"2016","journal-title":"Lancet Respir. Med."},{"issue":"24","key":"10.1016\/j.rmed.2025.108593_bib13","first-page":"1","article-title":"Review rethinking bronchiectasis as an inflammatory disease","volume":"2600","author":"Long","year":"2024"},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Mu\u00f1oz","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108593_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2024.01.045","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults","author":"Cordeiro","year":"2024","journal-title":"Chest [Internet]"},{"issue":"151","key":"10.1016\/j.rmed.2025.108593_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0108-2018","article-title":"A systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults","volume":"28","author":"Crichton","year":"2019","journal-title":"Eur. Respir. Rev."},{"issue":"7","key":"10.1016\/j.rmed.2025.108593_bib17","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/resp.14263","article-title":"Bronchiectasis enters the inflammation era","volume":"27","author":"Keir","year":"2022","journal-title":"Respirology [Internet]"},{"issue":"9","key":"10.1016\/j.rmed.2025.108593_bib18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1164\/rccm.201009-1414PP","article-title":"Addressing the complexity of chronic obstructive pulmonary disease","volume":"183","author":"Agusti","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.rmed.2025.108593_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1398-9995.2012.02832.x","article-title":"Untangling asthma phenotypes and endotypes","volume":"67","author":"Agache","year":"2012","journal-title":"Allergy [Internet]"},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/20734735.0119-2021","article-title":"Precision medicine in bronchiectasis","volume":"17","author":"Pembridge","year":"2021","journal-title":"Breathe"},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.pulmoe.2023.03.004","article-title":"Endotypes in bronchiectasis: moving towards precision medicine. A narrative review","volume":"29","author":"Martins","year":"2023","journal-title":"Pulmonology [Internet]"},{"issue":"9","key":"10.1016\/j.rmed.2025.108593_bib22","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib23","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00239-2023","article-title":"Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary","volume":"61","author":"Agust\u00ed","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01509-2019","article-title":"Targeting treatable traits in severe asthma: a randomised controlled trial","volume":"55","author":"McDonald","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"7","key":"10.1016\/j.rmed.2025.108593_bib27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/thoraxjnl-2012-202646","article-title":"Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?","volume":"68","author":"McDonald","year":"2013","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.jaip.2020.09.046","article-title":"Treatable traits that predict health status and treatment response in airway disease","volume":"9","author":"Hiles","year":"2021","journal-title":"J. allergy Clin. Immunol. Pract."},{"issue":"11","key":"10.1016\/j.rmed.2025.108593_bib29","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the NOVELTY study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"issue":"xxxx","key":"10.1016\/j.rmed.2025.108593_bib30","article-title":"Procalcitonin-guided use of antibiotic in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized clinical trial","author":"Sheng","year":"2025","journal-title":"Clin. Microbiol. Infect."},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02014-2018","article-title":"CRP-guided antibiotic treatment in acute exacerbations of COPD in hospital admissions","volume":"53","author":"Prins","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.rmed.2025.108593_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S2213-2600(19)30176-6","article-title":"Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial","volume":"7","author":"Sivapalan","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108593_bib33","doi-asserted-by":"crossref","DOI":"10.1177\/1479973119867954","article-title":"Treatable traits in acute exacerbations of chronic airway diseases","volume":"16","author":"McDonald","year":"2019","journal-title":"Chron. Respir. Dis."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-2600(21)00277-0","article-title":"Criteria and definitions for the radiological and clinical diagnosis of bronchiectasis in adults for use in clinical trials: international consensus recommendations","volume":"10","author":"Aliberti","year":"2022","journal-title":"Lancet Respir. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-023-02554-8","article-title":"Walking the path of treatable traits in interstitial lung diseases","volume":"24","author":"Amati","year":"2023","journal-title":"Respir. Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2020-000862","article-title":"\u201cIt's not one size fits all\u201d: a qualitative study of patients' and healthcare professionals' views of self-management for bronchiectasis","volume":"8","author":"Kelly","year":"2021","journal-title":"BMJ Open Respir. Res."},{"key":"10.1016\/j.rmed.2025.108593_bib38","first-page":"670","article-title":"Prevalence and types of treatable traits in bronchiectasis: a multicentre, cross-sectional study","author":"Cicchetti","year":"2025","journal-title":"ERJ Open Res."},{"issue":"December 2023","key":"10.1016\/j.rmed.2025.108593_bib39","article-title":"Applying the treatable traits approach in bronchiectasis-A scoping review of traits, measurements and treatments implemented by allied health professionals and nurses","volume":"222","author":"Watson","year":"2024","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib41","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4168\/aair.2023.15.1.83","article-title":"Impacts of asthma in patients with bronchiectasis: findings from the KMBARC registry","volume":"15","author":"Moon","year":"2023","journal-title":"Allerg. Asth. Immunol. Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib42","first-page":"1553","article-title":"Bronchiectasis and asthma: data from the european bronchiectasis registry (EMBARC)","volume":"61","author":"Morimoto","year":"2024","journal-title":"Respir. Investig."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib43","article-title":"Bronchiectasis and increased mortality in patients with corticosteroid-dependent severe asthma: a nationwide population study","volume":"14","author":"Choi","year":"2020","journal-title":"Ther. Adv. Respir. Dis."},{"key":"10.1016\/j.rmed.2025.108593_bib44","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202309-1614OC","article-title":"The association between bronchiectasis and chronic obstructive pulmonary disease: data from the european bronchiectasis registry (EMBARC)","author":"Polverino","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"August","key":"10.1016\/j.rmed.2025.108593_bib45","first-page":"1","article-title":"Chronic obstructive pulmonary disease is associated with decreased quality of life in bronchiectasis patients: findings from the KMBARC registry","volume":"8","author":"Kim","year":"2021","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib46","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.jaip.2019.02.026","article-title":"Prevalence and clinical implications of chronic rhinosinusitis in people with bronchiectasis: a systematic review","volume":"7","author":"Handley","year":"2019","journal-title":"J. Allerg. Clin. Immunol. Pract."},{"key":"10.1016\/j.rmed.2025.108593_bib47","first-page":"1087","article-title":"Bronchiectasis and sinonasal diseases: a narrative review","author":"Simonetta","year":"2025","journal-title":"ERJ Open Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/iid3.547","article-title":"The clinical impact of self-reported symptoms of chronic rhinosinusitis in people with bronchiectasis","volume":"10","author":"Lee","year":"2022","journal-title":"Immun. Inflamm. Dis."},{"issue":"9","key":"10.1016\/j.rmed.2025.108593_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0137348","article-title":"Impacts of co-existing chronic rhinosinusitis on disease severity and risks of exacerbations in Chinese adults with bronchiectasis","volume":"10","author":"Guan","year":"2015","journal-title":"PLoS One"},{"issue":"173","key":"10.1016\/j.rmed.2025.108593_bib50","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0038-2024","article-title":"Infection and the microbiome in bronchiectasis","volume":"33","author":"Mac Aog\u00e1in","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib51","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index an international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001369","article-title":"British thoracic society quality standard for clinically significant bronchiectasis in adults 2022","volume":"9","author":"Hill","year":"2022","journal-title":"BMJ Open Respir. Res."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib53","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"Ara\u00fajo","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.rmed.2025.108593_bib54","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1513\/AnnalsATS.201506-333OC","article-title":"A comprehensive analysis of the impact of Pseudomonas aeruginosa colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"14","key":"10.1016\/j.rmed.2025.108593_bib55","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.3390\/jcm11143960","article-title":"Impact of chronic bronchial infection by Staphylococcus aureus on bronchiectasis","volume":"11","author":"Garc\u00eda Clemente","year":"2022","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib56","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1513\/AnnalsATS.201706-426OC","article-title":"The prevalence and significance of Staphylococcus aureus in patients with non\u2013cystic fibrosis bronchiectasis","volume":"15","author":"Metersky","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12890-023-02823-8","article-title":"Understanding the effects of Haemophilus influenzae colonization on bronchiectasis: a retrospective cohort study","volume":"24","author":"Yang","year":"2024","journal-title":"BMC Pulm. Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-024-02904-0","article-title":"Phenotypical characteristics of nontuberculous mycobacterial infection in patients with bronchiectasis","volume":"25","author":"Frajman","year":"2024","journal-title":"Respir. Res."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/23120541.00060-2022","article-title":"Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis","volume":"8","author":"Suska","year":"2022","journal-title":"ERJ Open Res."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib60","first-page":"1","article-title":"Increased mortality in patients with non cystic fibrosis bronchiectasis with respiratory comorbidities","volume":"11","author":"Choi","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib61","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1164\/rccm.202307-1165OC","article-title":"Five-year outcomes among U.S. bronchiectasis and NTM research registry patients","volume":"210","author":"Aksamit","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib62","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02469-2017","article-title":"Prevalence, risk factors and prognosis of nontuberculous mycobacterial infection among people with bronchiectasis: a population survey","volume":"51","author":"Shteinberg","year":"2018","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib63","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/resp.12767","article-title":"Health\u2010related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: a systematic review","volume":"21","author":"Yeung","year":"2016","journal-title":"Respirology [Internet]"},{"issue":"11","key":"10.1016\/j.rmed.2025.108593_bib64","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib65","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"173","key":"10.1016\/j.rmed.2025.108593_bib66","first-page":"1","article-title":"Exacerbations of bronchiectasis","volume":"33","author":"De","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib67","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01213-2019","article-title":"Treatment to prevent exacerbations in bronchiectasis: macrolides as first line?","volume":"54","author":"Laska","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"10","key":"10.1016\/j.rmed.2025.108593_bib68","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.rmed.2025.108593_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(25)00160-2","article-title":"Symptoms, risk of future exacerbations, and response to long-term macrolide treatment in bronchiectasis: an observational study","author":"Sibila","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib70","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01554-2023","article-title":"Objective sputum colour assessment and clinical outcomes in bronchiectasis: data from the european bronchiectasis registry (EMBARC)","volume":"63","author":"Aliberti","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib71","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.00163208","article-title":"Sputum colour: a useful clinical tool in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib72","doi-asserted-by":"crossref","first-page":"4302","DOI":"10.21037\/jtd-2024-2106","article-title":"Addressing treatable traits in bronchiectasis through non-pharmacological therapies: a narrative review","volume":"17","author":"Lee","year":"2025","journal-title":"J. Thorac. Dis."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2018-000348","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"5","author":"Hill","year":"2018","journal-title":"BMJ Open Respir. Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib74","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European respiratory society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"176","key":"10.1016\/j.rmed.2025.108593_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1183\/16000617.0179-2024","article-title":"Neutrophilic inflammation in bronchiectasis","volume":"34","author":"Chalmers","year":"2025","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2025.108593_bib76","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/642503","article-title":"Neutrophilic bronchial inflammation correlates with clinical and functional findings in patients with noncystic fibrosis bronchiectasis","volume":"2015","author":"Dente","year":"2015","journal-title":"Mediat. Inflamm."},{"issue":"10","key":"10.1016\/j.rmed.2025.108593_bib77","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.rmed.2025.108593_bib78","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1164\/rccm.201712-2423OC","article-title":"Blood neutrophils are reprogrammed in bronchiectasis","volume":"198","author":"Bedi","year":"2018","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib79","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/resp.12219","article-title":"The sputum colour chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis","volume":"19","author":"Goeminne","year":"2014","journal-title":"Respirology [Internet]"},{"issue":"7","key":"10.1016\/j.rmed.2025.108593_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1164\/rccm.201203-0487OC","article-title":"Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis","volume":"186","author":"Chalmers","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib81","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.arbres.2022.09.004","article-title":"Pathophysiology of chronic bronchial infection in bronchiectasis","volume":"59","author":"Solarat","year":"2023","journal-title":"Arch. Bronconeumol."},{"issue":"8","key":"10.1016\/j.rmed.2025.108593_bib83","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib84","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00303-2019","article-title":"A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation","volume":"53","author":"Shoemark","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"December","key":"10.1016\/j.rmed.2025.108593_bib85","first-page":"1","article-title":"Dipeptidyl peptidase 1 inhibition as a potential therapeutic approach in neutrophil-mediated inflammatory disease","volume":"14","author":"Chalmers","year":"2023","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.rmed.2025.108593_bib86","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.rmed.2025.108593_bib87","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1056\/NEJMoa2411664","article-title":"Phase 3 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"392","author":"Chalmers","year":"2025","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.rmed.2025.108593_bib88","article-title":"Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF\u00ae, a phase II randomised, double-blind, placebo-controlled, dose-finding study","author":"Chalmers","year":"2024","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib89","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S2213-2600(25)00019-0","article-title":"Effects of the DPP-1 inhibitor HSK31858 in adults with bronchiectasis in China (SAVE-BE): a phase 2, multicentre, double-blind, randomised, placebo-controlled trial","volume":"13","author":"Zhong","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"7","key":"10.1016\/j.rmed.2025.108593_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines9070772","article-title":"T2-high endotype and response to biological treatments in patients with bronchiectasis","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"issue":"8","key":"10.1016\/j.rmed.2025.108593_bib91","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","article-title":"Characterization of eosinophilic bronchiectasis A European multicohort study","volume":"205","author":"Shoemark","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib92","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ccm.2021.12.002","article-title":"Allergic bronchopulmonary aspergillosis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Clin. Chest. Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib93","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.alit.2023.08.004","article-title":"Relationship between aspergillus and asthma","volume":"72","author":"Agarwal","year":"2023","journal-title":"Allergol. Int."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib94","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108593_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2024.06.3843","article-title":"Aspergillus serologic findings and clinical outcomes in patients with bronchiectasis: data from the european bronchiectasis registry","author":"Pollock","year":"2025","journal-title":"Chest [Internet]"},{"key":"10.1016\/j.rmed.2025.108593_bib96","doi-asserted-by":"crossref","DOI":"10.1513\/AnnalsATS.202306-551OC","article-title":"Bronchiectasis with chronic rhinosinusitis is associated with eosinophilic airway inflammation and is distinct from asthma","author":"Shteinberg","year":"2024","journal-title":"Ann. Am. Thorac. Soc."},{"key":"10.1016\/j.rmed.2025.108593_bib97","article-title":"Use of inhaled corticosteroids in bronchiectasis: data from the european bronchiectasis registry (EMBARC)","volume":"358\u201368","author":"Pollock","year":"2025","journal-title":"Thorax [Internet]"},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib98","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2303951","article-title":"Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts","volume":"389","author":"Bhatt","year":"2023","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.rmed.2025.108593_bib99","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1056\/NEJMoa2401304","article-title":"Dupilumab for COPD with blood eosinophil evidence of type 2 inflammation","volume":"390","author":"Bhatt","year":"2024","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib100","first-page":"7","article-title":"International rhinology journal european position paper on rhinosinusitis and nasal polyps","volume":"1","author":"Fokkens","year":"2020","journal-title":"Epos"},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib101","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01333-2019","article-title":"Anti-IL5 and anti-IL5R\u03b1 therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series","volume":"55","author":"Rademacher","year":"2020","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.rmed.2025.108593_bib102","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1016\/j.jaip.2023.05.041","article-title":"Real-world effectiveness of IL-5\/5Ra targeted biologics in severe eosinophilic asthma with comorbid bronchiectasis","volume":"11","author":"Bendien","year":"2023","journal-title":"J. Allerg. Clin. Immunol. Pract."},{"issue":"21","key":"10.1016\/j.rmed.2025.108593_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm13216309","article-title":"Clinical remission predictors in non-colonized bronchiectasis and severe asthma with type 2-Targeted biologic therapy: a retrospective real-life pilot study","volume":"13","author":"Quaranta","year":"2024","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.rmed.2025.108593_bib104","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01289-2017","article-title":"Standardised classification of the aetiology of bronchiectasis using an objective algorithm","volume":"50","author":"Ara\u00fajo","year":"2017","journal-title":"Eur. Respir. J."},{"issue":"AUG","key":"10.1016\/j.rmed.2025.108593_bib105","article-title":"The lung in primary immunodeficiencies: new concepts in infection and inflammation","volume":"9","author":"Baumann","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib106","doi-asserted-by":"crossref","first-page":"440","DOI":"10.4046\/trd.2024.0015","article-title":"Secondary immunodeficiency and non-cystic fibrosis bronchiectasis","volume":"87","author":"Zo","year":"2024","journal-title":"Tuberc. Respir. Dis. (Seoul)"},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib107","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1055\/s-0041-1730893","article-title":"Common variable immunodeficiency and other immunodeficiency syndromes in bronchiectasis","volume":"42","author":"McShane","year":"2021","journal-title":"Semin. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib108","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1183\/23120541.00388-2021","article-title":"Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients","volume":"8","author":"Aliberti","year":"2022","journal-title":"ERJ Open Res."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib109","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s13665-016-0154-8","article-title":"Bronchiectasis and connective tissue diseases","volume":"5","author":"Leung","year":"2016","journal-title":"Curr. Pulmonol. Rep."},{"key":"10.1016\/j.rmed.2025.108593_bib110","doi-asserted-by":"crossref","DOI":"10.1177\/1479973121994565","article-title":"A causal relationship between rheumatoid arthritis and bronchiectasis? A systematic review and meta-analysis","volume":"18","author":"Wiater","year":"2021","journal-title":"Chron. Respir. Dis."},{"issue":"April","key":"10.1016\/j.rmed.2025.108593_bib111","article-title":"Autoimmune diseases and their genetic link to bronchiectasis: insights from a genetic correlation and Mendelian randomization study","volume":"15","author":"Su","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib112","first-page":"224","article-title":"Pulmonary manifestations of systemic autoimmune diseases","volume":"6","author":"Cojocaru","year":"2011","journal-title":"Maedica (Buchar) [Internet]"},{"key":"10.1016\/j.rmed.2025.108593_bib113","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.rmed.2018.06.031","article-title":"A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: current understanding and future risk","author":"McDonnell","year":"2018","journal-title":"Respir. Med."},{"issue":"19","key":"10.1016\/j.rmed.2025.108593_bib114","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12196419","article-title":"Lung involvement in inflammatory bowel diseases: shared pathways and unwanted connections","volume":"12","author":"Cavalli","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.rmed.2025.108593_bib115","doi-asserted-by":"crossref","DOI":"10.1007\/s00408-024-00683-5","article-title":"Asymptomatic dysphagia and aspiration in patients with idiopathic bronchiectasis","author":"Perluk","year":"2024","journal-title":"Lung [Internet]"},{"issue":"12","key":"10.1016\/j.rmed.2025.108593_bib116","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12966","article-title":"The role of the lung microbiota and the gut-lung axis in respiratory infectious diseases","volume":"20","author":"Dumas","year":"2018","journal-title":"Cell Microbiol."},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib117","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1183\/23120541.01032-2023","article-title":"The impact of cardiovascular events in bronchiectasis: a systematic review and meta-analysis","volume":"10","author":"Gramegna","year":"2024","journal-title":"ERJ Open Res."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib118","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1513\/AnnalsATS.201706-488OC","article-title":"Cardiovascular outcomes after a respiratory tract infection among adults with non-cystic fibrosis bronchiectasis: a general population-based study","volume":"15","author":"Navaratnam","year":"2018","journal-title":"Ann. Am. Thorac. Soc."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib119","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5606\/tgkdc.dergisi.2021.20389","article-title":"Anxiety and depression as possible criteria in the treatment of bronchiectasis","volume":"29","author":"Keskin","year":"2021","journal-title":"Turkish J. Thorac. Cardiovasc. Surg."},{"issue":"2","key":"10.1016\/j.rmed.2025.108593_bib120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5578\/tt.69348","article-title":"Clinical impact of depression and anxiety in patients with non-cystic fibrosis bronchiectasis","volume":"68","author":"Bekir","year":"2020","journal-title":"Tuberk. Toraks."},{"issue":"11","key":"10.1016\/j.rmed.2025.108593_bib121","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.4187\/respcare.03905","article-title":"Low cognitive ability in subjects with bronchiectasis","volume":"60","author":"G\u00fclhan","year":"2015","journal-title":"Respir. Care"},{"issue":"11","key":"10.1016\/j.rmed.2025.108593_bib122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biomedicines9111573","article-title":"The isoform gc1f of the vitamin d binding protein is associated with bronchiectasis severity","volume":"9","author":"Oriano","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib123","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/thoraxjnl-2012-202125","article-title":"Vitamin-D deficiency is associated with chronic bacterial colonisation and disease severity in bronchiectasis","volume":"68","author":"Chalmers","year":"2013","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib124","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1371\/journal.pmed.0040115","article-title":"Malnutrition and infection: complex mechanisms and global impacts","volume":"4","author":"Schaible","year":"2007","journal-title":"PLoS Med."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib125","first-page":"169","article-title":"Differential expression of inflammatory responsive genes between chronic periodontitis and periodontally affected bronchiectasis patients","volume":"9","author":"Gupta","year":"2020","journal-title":"Mol. Biol. Res. Commun."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib126","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1177\/1479972312459973","article-title":"Systemic comorbidities in bronchiectasis","volume":"9","author":"Gale","year":"2012","journal-title":"Chron. Respir. Dis."},{"issue":"January","key":"10.1016\/j.rmed.2025.108593_bib127","first-page":"1","article-title":"Influence of comorbidities and airway clearance on mortality and outcomes of patients with severe bronchiectasis exacerbations in Taiwan","volume":"8","author":"Huang","year":"2022","journal-title":"Front. Med."},{"issue":"3","key":"10.1016\/j.rmed.2025.108593_bib128","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02210-2022","article-title":"Oxidised IL-33 drives COPD epithelial pathogenesis via ST2-independent RAGE\/EGFR signalling complex","volume":"62","author":"Strickson","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.rmed.2025.108593_bib129","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1183\/23120541.00433-2024","article-title":"Interleukin 33: a suitable target for biological therapies of COPD?","volume":"10","author":"Pelaia","year":"2024","journal-title":"ERJ Open Res."},{"issue":"12","key":"10.1016\/j.rmed.2025.108593_bib130","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1080\/02770903.2021.2020815","article-title":"Interleukin (IL)-33 immunobiology in asthma and airway inflammatory diseases","volume":"59","author":"Gaurav","year":"2022","journal-title":"J. Asthma"},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib131","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/j.1476-5381.1992.tb14451.x","article-title":"Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors","volume":"106","author":"de Boer","year":"1992","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.rmed.2025.108593_bib132","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2019.02.002","article-title":"Phosphodiesterases as therapeutic targets for respiratory diseases","volume":"197","author":"Zuo","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.rmed.2025.108593_bib133","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1080\/14656566.2025.2491515","article-title":"Ensifentrine: a novel approach to redefining COPD management and implications for additional respiratory diseases","volume":"26","author":"Sciurba","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib134","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.202306-0944OC","article-title":"Ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor for the treatment of chronic obstructive pulmonary disease: randomized, double-blind, placebo-controlled, multicenter phase III trials (the ENHANCE trials)","volume":"208","author":"Anzueto","year":"2023","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.rmed.2025.108593_bib135","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.200909-1434OC","article-title":"Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis","volume":"181","author":"Bienvenu","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"SUPPL. 2","key":"10.1016\/j.rmed.2025.108593_bib136","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1569-1993(11)60014-3","article-title":"Recommendations for the classification of diseases as CFTR-related disorders","volume":"10","author":"Bombieri","year":"2011","journal-title":"J. Cyst. Fibros."},{"issue":"4","key":"10.1016\/j.rmed.2025.108593_bib137","article-title":"Treating non-cystic fibrosis bronchiectasis with CFTR modulators: early case reports","volume":"9","author":"Swenson","year":"2024","journal-title":"Ann. Case Rep."},{"issue":"2 February","key":"10.1016\/j.rmed.2025.108593_bib138","first-page":"1","article-title":"Evaluating elexacaftor\/tezacaftor\/ivacaftor (ETI; TrikaftaTM) for treatment of patients with non-cystic fibrosis bronchiectasis (NCFBE): a clinical study protocol","volume":"20","author":"Swenson","year":"2025","journal-title":"PLoS One"},{"issue":"171","key":"10.1016\/j.rmed.2025.108593_bib139","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0178-2023","article-title":"Eradication treatment for Pseudomonas aeruginosa infection in adults with bronchiectasis: a systematic review and meta-analysis","volume":"33","author":"Concei\u00e7\u00e3o","year":"2024","journal-title":"Eur. Respir. Rev."},{"issue":"August","key":"10.1016\/j.rmed.2025.108593_bib140","first-page":"1","article-title":"Biofilm aggregates and the host airway-microbial interface","volume":"12","author":"Hall-Stoodley","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.rmed.2025.108593_bib141","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1164\/rccm.202308-1403OC","article-title":"A bispecific monoclonal antibody targeting psl and PcrV enhances neutrophil-mediated killing of Pseudomonas aeruginosa in patients with bronchiectasis","volume":"210","author":"Long","year":"2024","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"Abstracts","key":"10.1016\/j.rmed.2025.108593_bib142","article-title":"A bispecific monoclonal antibody targeting psl and PcrV for chronic Pseudomonas aeruginosa infection in patients with bronchiectasis: results from a randomized, double-blind placebo-controlled trial (GREAT-2)","volume":"211","author":"Long","year":"2025","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125006560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611125006560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:29:24Z","timestamp":1777595364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611125006560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":141,"alternative-id":["S0954611125006560"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108593","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis and treatable traits: the journey from concept to clinical practice","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108593"}}